Insider Transactions in Q1 2023 at Insmed Inc (INSM)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
3,798
-1.35%
|
-
|
|
Jan 10
2023
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,439
-4.51%
|
$61,902
$18.06 P/Share
|
|
Jan 10
2023
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
6,994
-2.57%
|
$125,892
$18.0 P/Share
|
|
Jan 10
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
2,435
-3.26%
|
$41,395
$17.95 P/Share
|
|
Jan 10
2023
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,836
-3.27%
|
$31,212
$17.93 P/Share
|
|
Jan 10
2023
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
779
-1.0%
|
$13,243
$17.96 P/Share
|
|
Jan 10
2023
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,194
-2.3%
|
$54,298
$17.99 P/Share
|
|
Jan 10
2023
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,857
-4.15%
|
$51,426
$18.12 P/Share
|
|
Jan 05
2023
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,332
+10.13%
|
-
|
|
Jan 05
2023
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
720
-1.42%
|
$13,680
$19.72 P/Share
|
|
Jan 05
2023
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,598
+8.87%
|
-
|
|
Jan 05
2023
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,160
-1.62%
|
$22,040
$19.74 P/Share
|
|
Jan 05
2023
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,144
+6.96%
|
-
|
|
Jan 05
2023
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,374
-2.07%
|
$26,106
$19.73 P/Share
|
|
Jan 05
2023
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,353
+7.59%
|
-
|
|
Jan 05
2023
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
7,008
-2.73%
|
$133,152
$19.8 P/Share
|
|
Jan 05
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,332
+7.82%
|
-
|
|
Jan 05
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,448
-2.08%
|
$27,512
$19.73 P/Share
|
|
Jan 05
2023
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,297
+9.14%
|
-
|
|
Jan 05
2023
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,598
+5.19%
|
-
|
|
Jan 05
2023
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,044
-2.27%
|
$57,836
$19.75 P/Share
|